AASLD

10/17/2026

Keep the latest liver research in your feed. 🔬

Follow the AASLD Publications Showcase on LinkedIn for monthly highlights from , , and , featuring noteworthy studies, emerging insights, and research advancing liver disease care.

📲 Stay connected to the research shaping the future of hepatology: https://bit.ly/44Qh0jj

10/16/2026

🏅 Turn your contributions into recognition.

Your work is helping advance . Take the next step by applying for Fellow of the AASLD (FAASLD) or Associate Fellow of the AASLD recognition.

Join a distinguished community of professionals recognized for their contributions to research and care.

🔗 Learn more and apply by Tuesday, Dec. 15: https://bit.ly/3DafgH0.

10/16/2026

The CDC’s Division of Viral Hepatitis has released its 2030 Strategic Plan, outlining key priorities to prevent new infections, reduce viral hepatitis-related illness and deaths, address health disparities, and strengthen public health surveillance.

AASLD applauds this important step forward and remains committed to supporting efforts to expand testing, vaccination, treatment, and access to care.

Continued investment and collaboration are essential to advancing our shared goal of eliminating viral hepatitis.

🔗 Learn more at the AASLD Policy Communications webpage: https://www.aasld.org/policy-communications

10/15/2026

🆕 Introducing AASLD EXPOs!

AASLD has published its first-ever Expert-Based Practice Opinion , launching a new type of clinical resource designed to deliver timely, expert-informed recommendations in areas of hepatology where evidence is limited, emerging, or rapidly evolving.

Published in , the inaugural AASLD EXPO on addresses the contemporary role of liver biopsy, including patient selection, biopsy technique, safety and monitoring, specimen adequacy and pediatric considerations.

This first EXPO reflects an evolving landscape in liver disease care, including advances in noninvasive assessment and endoscopic ultrasound-guided liver biopsy (EUS-LB).

🔗 Read the first AASLD EXPO: https://bit.ly/4dH2I9l

10/15/2026

Keep your education on-the-go with our Oct. 27 webinar discussing newly proposed definitions of and the genetic and metabolic factors in the pathogenesis of lean . Hear from the experts on this timely discussion and register today https://bit.ly/3W5SXeQ.

10/15/2026

🎉 A historic milestone for AASLD journals!

has achieved its highest-ever of 21.3, reinforcing its position as a global leader in liver research and scientific discovery.

The milestones don't stop there! also reached a record-high Impact Factor of 6.2.

These achievements reflect the exceptional contributions of our authors, reviewers, and editorial teams and AASLD's continued commitment to advancing liver science and improving patient care worldwide.

Read the full announcement: https://bit.ly/4jndxRJ

10/15/2026

Come for the science and stay for the community. 🫶 Nothing replaces being in the same space with people who share your passion!

Who’s ready to expand their network and reconnect with the hepatology family? Drop a 💚 if we'll see you there!

10/14/2026

This , AASLD is committed to advancing the research that can shape the future of liver cancer prevention, diagnosis and care.

The Pilot Research Award in Hepatocellular Carcinoma supports innovative research with the potential to move the field forward.

Learn more ⬇️

Have a bold idea that could advance research?

The AASLD Foundation Pilot Research Award in Hepatocellular Carcinoma provides $60,000 in funding for one year to help investigators test highly innovative, high-risk/high-reward ideas and generate the data needed to pursue larger-scale funding. Preference will be given to research related to HCC biomarkers.

🔬 Basic, clinical, translational, and outcomes research are eligible.

📅 Apply by Dec. 7, 2026.

Learn more and apply: https://bit.ly/4yHXlzm

10/14/2026

🗳️ The results are in!

Congratulations to AASLD’s newly elected leaders! Thank you to all members who participated in the 2027 General Election.

Meet your newly elected leaders below. ⬇️

10/14/2026

🔥 HOT TOPIC

📘

Nearly 1 in 5 youth with biopsy-confirmed began drinking during adolescence or early adulthood.

In the largest longitudinal study of its kind, researchers followed more than 1,100 youth and found that alcohol use was associated with faster increases in liver enzymes, reinforcing the importance of routine alcohol screening and developmentally tailored counseling in pediatric MASLD care.

Read the article: https://bit.ly/4rPDaN0